Clorox to Buy Purell-Maker Gojo for $2.25 Billion
Clorox adds the hand sanitizer brand to its stable of cleaning and other consumer products
By Josh Beckerman
Updated Jan. 22, 2026 4:59 pm ET
Clorox is buying Purell-maker Gojo Industries for $2.25 billion. brian snyder/Reuters
Quick Summary
- Clorox is acquiring Gojo Industries, the maker of Purell hand sanitizer, for $2.25 billion.View more
Clorox CLX 1.14%increase; green up pointing triangle is buying Purell-maker Gojo Industries for $2.25 billion, adding the hand sanitizer brand to its stable of cleaning and other consumer products.
Clorox said the all-cash deal, which is being funded with debt, will help it expand further into the health and hygiene categories. It plans to accelerate growth of the Purell brand, while using Gojo’s business-to-business reach to give a lift to its professional business.
After considering tax benefits valued at roughly $330 million, Clorox said the net purchase price comes to about $1.92 billion.
The Akron, Ohio.-based Gojo benefited from a surge in demand during the pandemic, as consumers and businesses snapped up Purell to protect against infection.
The product, an ethyl alcohol-based hand cleaner that dries on its own, was invented in 1988, and later sold to Warner-Lambert, a Pfizer unit, in 2004. It changed hands again before Gojo reacquired full control of Purell in 2010 from Johnson & Johnson.
The Wall Street Journal reported in April 2023 that Gojo was seeing a buyer. People familiar with the matter said at the time that the company could be valued at about $3 billion, with industry players the likely buyers over private-equity firms.
Gojo currently has nearly $800 million in annual sales, with sales growing at an average of 5% over the last three years. More than 80% of sales come from business-to-business distributors, which is helped by some 20 million soap and sanitizer dispensers that help drive recurring sales.
Clorox, whose brands include Glad, Liquid-Plumr, Burt’s Bees and Kingsford, said the deal will help boost growth and support its long-term sales growth target of between 3% and 5%. It expects to generate at least $50 million in cost savings from the deal, which is expected to close by the end of June and will be accretive to its adjusted per-share earnings in the second year of ownership.
Clorox said that excluding the impact from the transaction, it reaffirms its fiscal year 2026 outlook for net sales, earnings per share and adjusted earnings per share.
Clorox shares fell 1.1% in late trading to $111. Through Thursday’s close, the stock had fallen nearly 30% over the last year, though has gained more than 11% to start this year.
Write to Josh Beckerman at josh.beckerman@wsj.com
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
What to Read Next
Procter & Gamble Revenue Ticks Up, Helped by Higher Prices
January 22, 2026
Procter & Gamble posted slightly higher revenue in its fiscal second quarter as higher prices helped offset a decline in volumes.
Why Berkshire Put Its Kraft Stake on the Block
January 22, 2026
Plus, the framework of a Greenland deal sparks a stock-market rebound
Health Care Roundup: Market Talk
January 20, 2026
Find insight on GSK’s acquisition of RAPT Therapeutics, Novartis and more in the latest Market Talks covering Health Care.
GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments
January 20, 2026
The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in cash.
Henkel in Talks Over Potential Acquisition of Specialty-Chemicals Company Stahl
January 20, 2026
The management board of Henkel said it was in discussions with investment firm Wendel, the majority owner of Stahl, over a possible deal.
The Man Who Almost Replaced Warren Buffett
11 hours ago
David Sokol was seen as the next likely CEO of Berkshire Hathaway—until a controversy arose over his personal trades.
Clorox to buy Purell maker for more than $2 billion, eyeing 20 million hand-sanitizer dispensers and more
January 23, 2026
A deal would underscore broad investor interest in an important, though not flashy, corner of the healthcare business involving services and products to hospitals.
Sophia Loren and Jane Russell: This Week in Celebrity Homes
11 hours ago
Take a video tour of the recent real estate happenings with celebrity cachet
Bain CEO: What CEOs Must Do Now to Lead Through AI and Geopolitical ChangeBloom Energy CEO: AI Can’t Rely on the Power Grid AnymoreWSJ Opinion: What Is Free Expression?
Buy Side is independent of The Wall Street Journal newsroom.
Best Business Debt Consolidation Loans in January 2026
Cheapest Car Insurance Options 2026
6 of the Best Financial Advisor Companies: Well-Known Fiduciary Investment Firms to Consider
Best Term Life Insurance Companies of 2026
Affordable Pet Insurance Options: Balancing Cost and Coverage
Best High-Yield Savings Accounts for January 2026: Up to 4.31%
Real Estate Insights

Six Major Metros Are Building More Housing—but Only for the Rich

EXCL: Billionaire Ron Burkle Lists His Malibu Beach ‘Cottage’ for $20 Million

Hollywood Siren Kelly LeBrock Reveals Why She Quit L.A. To Become a ‘Recluse’

Inside Kimberly Guilfoyle’s Glamorous New Life in Greece

Jennifer Lawrence Lifts the Lid on Home Life With Cooke Maroney and Kids

Nvidia CEO Jensen Huang Predicts Huge Increase in ‘Six-Figure’ Construction Jobs Because of AI Data Centers
View this Wall Street Journal article CLICK HERE
Leave a comment